To present optimized chromatographic systems for radiochemical purity (RCP) evaluation of 99m Tc-eluate and 99m Tc-radiopharmaceuticals, as well as to assess doses calibrator reliability for routine purposes in hospital radiopharmacies. RCP was determined by different systems and radioactivity was quantified by TLC-scanner, doses calibrator and gamma-counter. Suitable and optimized systems were presented for RCP analyses. No significant differences were observed between radioactivity counting devices and, thus, doses calibrator showed reliability for RCP determination in hospital radiopharmacies.
INTRODUCTION
Radiopharmacy is a pharmaceutical specialty concerning to development, production, manipulation, quality control, and dispensing of radiopharmaceuticals, which are specific molecules for imaging diagnosis and/or treatment in nuclear medicine [1] . In Brazil, radiopharmaceutical practices must be under the Brazilian Health Surveillance Agency (ANVISA) and the National Commission of Nuclear Energy (CNEN) guidelines.
Currently, most of the radiopharmaceuticals used in nuclear medicine for diagnosis purposes are freeze-dried kits for in situ radiolabelling with sodium pertechnetate (Na 99m TcO4 -). Freeze-dried formulations aim to increase product stability, allowing a reliable process and easy radiopharmaceutical reconstitution [2] .
Radiopharmaceuticals present peculiarities related to their production and quality control, due to the presence of radionuclide in its composition and to the administration via, which is mostly intravenous [1] . Therefore, they must be under the Good Manufacturing Production (GMP) rules, as established in the Collegiate Board of Directors Resolution (RDC) no. 63/2009 by ANVISA, along with specific quality control tests that must be performed [3] .
In [4] . Prior to the RDC no. 38/2008, hospital radiopharmacies did not perform quality control assays of their products, which was an exclusive responsibility of the industrial radiopharmacy. After ANVISA`s regulations were published, hospital radiopharmacies had to adapt their routine to these new procedures, specially to the determination of 99m Tc-radiophamaceuticals` radiochemical purity (RCP).
RCP is defined as the total radioactivity percentage present in the desired chemical form in a radiopharmaceutical, that is, bound 99m Tc to the ligand of interest. Free 99m Tc ( 99m TcO4 -) and hydrolyzed-reduced 99m Tc ( 99m TcO2) are classified as radiochemical impurities [5] . In industrial radiopharmacy, RCP determination is performed in devices, such as gamma-counter and thin layer chromatography (TLC)-scanner, due to their high counting sensitivity [6] . On the other hand, in hospital radiopharmacy, doses calibrator is commonly used to measure chromatographic stripes, once it is usually available, despite of its lower sensitivity when compared to the formers.
Based in this scenario, specially concerning to RDC no. 38/2008 implementation in the Brazilian legislation and, therefore, the requirement of hospital radiopharmacy routine adaptation, this short note aims to present the most cost-benefit chromatographic systems for the RCP evaluation of 99m Tc-eluate and 99m Tc-radiopharmaceuticals, as well as to assess doses calibrator reliability for nuclear medicine routine.
MATERIAL AND METHODS
To achieve those goals, we have revised chromatographic systems previously described in the literature. These methods were reproduced in our research laboratory in order to compare technical parameters, like reproducibility, effectiveness, cost, speed and easiness of execution. We have made slight modifications in some systems, compared to the respective references available, like changes in both stationary/mobile phases and chromatographic strip`s cutoff, intending routine improvement. It is important to highlight that each radiopharmaceutical, in this work, was radiolabeled with 99m TcO4in four different batches and RCP analyses were performed by ascendant chromatography in triplicate. Strips' radioactivities were quantified in the following sequence: TLC-scanner (AR-2000, Eckert & Ziegler ® , Germany), dose calibrator (CRC-25R, Capintec ® , USA), and automatic gamma-counter (Wizard 3' 2480, Perkin Elmer ® , USA).
RESULTS AND DISCUSSION
Ascendant chromatographic parameters, chromatographic systems, cutoff and Rf, for RCP analyses of 99m Tc-eluate and the evaluated 99m Tc-radiopharmaceuticals are described in Table 1 . Table 1 refer to the most commonly used in nuclear medicine services for radiolabeling with 99m Tc, and also 99m Tc-eluate. The purposed chromatographic systems were selected taking into account some technical aspects.
Radiopharmaceuticals presented in
We have selected the chromatographic systems considering stationary and mobile phases, besides time of chromatographic development. Concerning to stationary phases, the majority of the chosen systems employ 3MM chromatography paper, once it is the cheapest chromatographic strip compared to the others available for ascendant chromatography. When 3MM chromatography paper was not suitable, thin layer chromatography-silica gel aluminum plates -TLC-SG (Al) -were selected. In terms of mobile phases, we have taken into account good availability, purchase control by authorities, waste disposal with lower cost, easy preparation, low risk and toxicity to the professional. It was also prioritized shorter chromatographic developments, in order to speed up radiopharmaceutical dispensing for patients.
Furthermore, strip`s cutoffs were validated by means of TLC-scanner, which is gold standard for chromatographic strips counting [6] . When possible, cutoff in the half of the stationary phase was prioritized for standardize counting in doses calibrator.
In the specific case of 99m Tc-Bicisate ( 99m Tc-ECD-TEC), a single chromatographic system was selected considering practical aspects, previously described. Beyond that, for Brazilian Archives of Biology and Technology. Vol.62: e19180545, 2019 www.scielo.br/babt 99m Tc-Sestamibi ( 99m Tc-MIBI-TEC) and 99m Tc-Disofenin ( 99m Tc-DISI-TEC), we have proposed and validated new methods, also considering an optimized and operative routine.
Some radiopharmaceuticals, like 99m Tc-Colloidal TIN ( 99m Tc-TIN-TEC), 99m Tc-Macrosalb ( 99m Tc-PUL-TEC), 99m Tc-Phytate ( 99m Tc-FITA-TEC) and 99m Tc-Dextran ( 99m Tc-DEX (70 / 500)-TEC), present colloidal features in their composition and, thus, may not be separated from 99m TcO2. Therefore, a single system was selected, in order to determine only the amount of 99m TcO4 -.
TLC-scanner and automatic gamma-counter are both more sensitive devices than dose calibrator [6] . However, the latter is most commonly used in the routine activities of hospital radiopharmacy and, then, it is usually available to measure chromatographic strips for RCP analysis [1] . Thus, in order to confirm the effectiveness of dose calibrator as a reliable counting instrument for RCP assays, the radiopharmaceuticals 99m Tc-eluate, 99m Tc-Pentetate and 99m Tc-Macrosalb were evaluated in the previously mentioned radioactivity counting devices. Our results are summarized in Table 2 and compared to TLC-scanner data (Figure 1) . The RCP data were similar for all counting devices, with no statistical significant differences between means (p-values > 0.05). Therefore, our results indicate that dose calibrator can be used in routine activities for RCP evaluation, although it is less sensitive than TLC-scanner and automatic gamma-counter. Furthermore, it is important to point out that dose calibrator is already available for other purposes in a hospital radiopharmacy, and also it is cheaper and easier to use when compared to the others.
CONCLUSION
In summary, considering RDC no. 38/2008 and, thus, the requirement of hospital radiopharmacy routine adequacy, this mini-review presented optimized chromatographic systems for RCP evaluation of 99m Tc-eluate and the most commonly used 99m Tc-radiopharmaceuticals. Additionally, we have confirmed that dose calibrator is reliable for routine purposes and can be used for RCP analysis daily, providing adequacy of hospital radiopharmacy activities to the ANVISA`s regulation. Finally, it is important to emphasize the requirement of the RCP methods validation, as well as of any slight modifications in the chromatographic systems, such as stationary/mobile phase exchange or chromatographic strips size.
